Depressed natural killer cell activity in acute myocardial infarction

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Depressed natural killer cell activity in acute myocardial infarction. / Klarlund, K; Pedersen, B K; Theander, T G; Andersen, V.

I: Clinical and Experimental Immunology, Bind 70, Nr. 1, 1987, s. 209-16.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Klarlund, K, Pedersen, BK, Theander, TG & Andersen, V 1987, 'Depressed natural killer cell activity in acute myocardial infarction', Clinical and Experimental Immunology, bind 70, nr. 1, s. 209-16.

APA

Klarlund, K., Pedersen, B. K., Theander, T. G., & Andersen, V. (1987). Depressed natural killer cell activity in acute myocardial infarction. Clinical and Experimental Immunology, 70(1), 209-16.

Vancouver

Klarlund K, Pedersen BK, Theander TG, Andersen V. Depressed natural killer cell activity in acute myocardial infarction. Clinical and Experimental Immunology. 1987;70(1):209-16.

Author

Klarlund, K ; Pedersen, B K ; Theander, T G ; Andersen, V. / Depressed natural killer cell activity in acute myocardial infarction. I: Clinical and Experimental Immunology. 1987 ; Bind 70, Nr. 1. s. 209-16.

Bibtex

@article{ec4902c0a0dc11dd86a6000ea68e967b,
title = "Depressed natural killer cell activity in acute myocardial infarction",
abstract = "Natural killer (NK) cell activity against K562 target cells was measured in patients within 24 h of acute myocardial infarction (AMI) and regularly thereafter for 6 weeks. NK cell activity was suppressed on days 1, 3, and 7 (P less than 0.01), day 14 (P less than 0.05) and at 6 weeks (P = 0.05) when compared to controls. Interferon, interleukin 2 and indomethacin enhanced NK cell activity on all days measured, but did not completely restore the defective NK cell activity. Serum from the patients did not suppress the NK cell activity of healthy mononuclear cells. The number of NK cells, identified as large granular lymphocytes (LGL), measured on days 1, 3, and 14 and at 6 weeks was not reduced in comparison to that of controls. Thus, the defective NK cell activity can be characterized as functional.",
author = "K Klarlund and Pedersen, {B K} and Theander, {T G} and V Andersen",
note = "Keywords: Adult; Aged; Aged, 80 and over; Cytotoxicity, Immunologic; Female; Humans; Indomethacin; Interferon Type I; Interleukin-2; Killer Cells, Natural; Leukocyte Count; Male; Middle Aged; Myocardial Infarction",
year = "1987",
language = "English",
volume = "70",
pages = "209--16",
journal = "Clinical and Experimental Immunology, Supplement",
issn = "0964-2536",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - Depressed natural killer cell activity in acute myocardial infarction

AU - Klarlund, K

AU - Pedersen, B K

AU - Theander, T G

AU - Andersen, V

N1 - Keywords: Adult; Aged; Aged, 80 and over; Cytotoxicity, Immunologic; Female; Humans; Indomethacin; Interferon Type I; Interleukin-2; Killer Cells, Natural; Leukocyte Count; Male; Middle Aged; Myocardial Infarction

PY - 1987

Y1 - 1987

N2 - Natural killer (NK) cell activity against K562 target cells was measured in patients within 24 h of acute myocardial infarction (AMI) and regularly thereafter for 6 weeks. NK cell activity was suppressed on days 1, 3, and 7 (P less than 0.01), day 14 (P less than 0.05) and at 6 weeks (P = 0.05) when compared to controls. Interferon, interleukin 2 and indomethacin enhanced NK cell activity on all days measured, but did not completely restore the defective NK cell activity. Serum from the patients did not suppress the NK cell activity of healthy mononuclear cells. The number of NK cells, identified as large granular lymphocytes (LGL), measured on days 1, 3, and 14 and at 6 weeks was not reduced in comparison to that of controls. Thus, the defective NK cell activity can be characterized as functional.

AB - Natural killer (NK) cell activity against K562 target cells was measured in patients within 24 h of acute myocardial infarction (AMI) and regularly thereafter for 6 weeks. NK cell activity was suppressed on days 1, 3, and 7 (P less than 0.01), day 14 (P less than 0.05) and at 6 weeks (P = 0.05) when compared to controls. Interferon, interleukin 2 and indomethacin enhanced NK cell activity on all days measured, but did not completely restore the defective NK cell activity. Serum from the patients did not suppress the NK cell activity of healthy mononuclear cells. The number of NK cells, identified as large granular lymphocytes (LGL), measured on days 1, 3, and 14 and at 6 weeks was not reduced in comparison to that of controls. Thus, the defective NK cell activity can be characterized as functional.

M3 - Journal article

C2 - 3500813

VL - 70

SP - 209

EP - 216

JO - Clinical and Experimental Immunology, Supplement

JF - Clinical and Experimental Immunology, Supplement

SN - 0964-2536

IS - 1

ER -

ID: 6767091